Senate Decision Maintains AI Pilot in Medicare
The Senate voted against a Democratic-led resolution to end a Centers for Medicare & Medicaid Services (CMS) pilot program. This program uses artificial intelligence (AI) to review certain Medicare treatment requests. The initiative could enable private contractors to delay or deny necessary care for seniors. Proponents argue it aims to reduce waste, fraud, and unnecessary treatments in Medicare.
“CMS is committed to crushing fraud, waste, and abuse,” stated Michael Ryan, a finance expert.
The vote resulted in 46 Democrats supporting the resolution and 50 Republicans opposing it, keeping the AI pilot program intact. Four senators abstained from voting.
Implications of AI in Healthcare Decisions
The AI pilot program has raised national concerns about its impact on healthcare decisions. Critics argue that it could import a controversial prior authorization system into traditional Medicare. This might slow seniors’ access to care, a factor that distinguishes traditional Medicare from Medicare Advantage and private insurance plans.
If expanded, millions of beneficiaries might face additional approval layers for treatments.
Senators Opposed to Repealing AI
The following Republicans voted to maintain the WISeR program:
- Alan Armstrong (Oklahoma)
- Jim Banks (Indiana)
- John Barrasso (Wyoming)
- Marsha Blackburn (Tennessee)
- John Boozman (Arkansas)
- [Additional names omitted for brevity]
Operating in six states, the WISeR model requires prior authorization for medical services vulnerable to fraud and misuse. CMS contracts with companies using AI-assisted technology for these reviews.
“AI isn’t the danger. But paying outsiders to say no to seniors’ care is,” said Michael Ryan.
Why Democrats Sought Repeal
Democratic senators, led by Ron Wyden and Patty Murray, argue that the program delays care for seniors. Murray stated that AI-driven prior authorization burdens patients and doctors, slowing access to necessary treatments.
A report by Maria Cantwell found that the program significantly increased authorization times in Washington state hospitals.
“Americans are tired of abusive prior authorization tactics,” Wyden stated.
Legislative Path to the Senate
The resolution gained momentum after the Government Accountability Office deemed the CMS notice a rule under the Congressional Review Act. This allows Congress to overturn it with a resolution of disapproval.
Utilizing the CRA, the resolution aimed to nullify the CMS rule, highlighting concerns about AI’s role in healthcare decisions.
Despite AI’s potential to streamline processes, critics caution that its implementation in Medicare remains premature. CMS notes the program targets services prone to improper billing, leveraging AI and human review to ensure appropriate Medicare payment.
“AI doesn’t eliminate bias; it often amplifies existing biases,” stated Kevin Thompson, CEO of 9i Capital Group.
Future Steps
The Senate’s decision allows the Trump administration’s WISeR model to continue in six states. “Democrats tried to stop AI prior authorization in Medicare. Republicans blocked it,” Murray commented.
The program remains operational in Arizona, New Jersey, Ohio, Oklahoma, Texas, and Washington. Here, specific Medicare services undergo prior authorization or pre-payment review.
Michael Ryan noted, “This vote decides Medicare’s future, maintaining traditional aspects or shifting toward Advantage plans’ gatekeeping model.”